Shoreline Biosciences
Pre-clinicalWe Are Pushing the Boundaries of Science to the Edge of What’s Possible We are passionate about delivering novel therapies to patients in need by harnessing our cutting-edge approach in cellular immunotherapy. We are building a pipeline of iPSC-derived natural killer cell (iNK) and macrophage (iMACs) cellular immunotherapy candidates derived from our deep expertise in […]
Private Company
Total funding raised: $183M
About
We Are Pushing the Boundaries of Science to the Edge of What’s Possible We are passionate about delivering novel therapies to patients in need by harnessing our cutting-edge approach in cellular immunotherapy. We are building a pipeline of iPSC-derived natural killer cell (iNK) and macrophage (iMACs) cellular immunotherapy candidates derived from our deep expertise in […]